Target intelligence / Profile preview

Asparagine synthetase pseudogene 3 (ASNSP3)

Target
ASNSP3
Molecular classification
Pseudogene
01

Overview

Asparagine synthetase pseudogene 3 (ASNSP3) is a human pseudogene related to the functional asparagine synthetase gene (ASNS). Pseudogenes are genomic DNA sequences similar to normal genes but typically non-coding due to disabling mutations and generally do not produce functional proteins[2]. Some pseudogenes, including ASNSP3, may be transcribed and participate in gene regulation at the RNA level, such as acting as antisense transcripts or competing endogenous RNAs that modulate their parental gene's expression[2][4]. ASNSP3 itself is not known to encode a functional asparagine synthetase enzyme and is therefore not a therapeutic target like the protein-coding ASNS gene. There is no evidence associating ASNSP3 directly with disease or drug interaction; its precise biological relevance remains largely uncharacterized and is likely limited to possible RNA-mediated regulatory functions seen in other pseudogenes[2][4]. Notes on interpretation: - ASNSP3 refers to a *pseudogene*, not a functional enzyme, receptor, transporter, or other typical drug target class[2]. - There is no evidence in the scientific literature that ASNSP3 (asparagine synthetase pseudogene 3) is a validated therapeutic target, biomarker, or has any disease association distinct from its parent gene, ASNS. - If the actual intended target was *ASNS* (asparagine synthetase), that is a well-characterized enzyme with demonstrated disease roles (see sources for ASNS for more[1][3][5]). - Pseudogenes can play regulatory RNA roles but are generally not pursued as drug targets unless specific RNA-mediated effects are demonstrated in disease contexts[2][4].

Other names
ASNSP3asparagine synthetase pseudogene 3
02

Biological functions

Potential RNA-level regulatory function (e.g., antisense RNA, competing endogenous RNA)Other
03

Disease associations

Other

Beyond the preview

Go deeper on Asparagine synthetase pseudogene 3 (ASNSP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asparagine synthetase pseudogene 3 (ASNSP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call